studio randomizzato controllato
Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial--VIP report no. 3 / BLINDER KJ; BLUMENKRANZ MS; BRESSLER NM; BRESSLER SB; DONATO G; LEWIS H; LIM JI; MENCHINI U; MILLER JW; MONES JM; POTTER MJ; POURNARAS C; REAVES A; ROSENFELD P; SCHACHAT AP; SCHMIDT-ERFURTH U; SICKENBERG M; SINGERMAN LJ; SLAKTER JS; STRONG HA; G. VIRGILI; WILLIAMS GA.. - In: OPHTHALMOLOGY. - ISSN 0161-6420. - STAMPA. - 110:(2003), pp. 667-773. [10.1016/S0161-6420(02)01998-X]
Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial--VIP report no. 3.
MENCHINI, UGO;VIRGILI, GIANNI;
2003
Abstract
studio randomizzato controllatoFile in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.